Invitrogen Sues GE Over Enzyme Kit Patents
Biotech company Invitrogen Corp. hit General Electric Co.'s health care subsidiary with two lawsuits on Wednesday, alleging that GE is willfully infringing several patents related to reverse transcriptase enzyme kits and...To view the full article, register now.
Already a subscriber? Click here to view full article